BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.
about
Targeted approaches to induce immune tolerance for Pompe disease therapyB cells with regulatory properties in transplantation toleranceResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentCD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absenceProtective antiviral antibody responses in a mouse model of influenza virus infection require TACIBAFF mediates splenic B cell response and antibody production in experimental Chagas disease.VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicryB lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.APRIL mediates peritoneal B-1 cell homeostasis.B cells and humoral immunity in atherosclerosisEffect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.Lupus nephritis: lessons from murine modelsB-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Germinal center selection and the development of memory B and plasma cells.A role for IL-27p28 as an antagonist of gp130-mediated signaling.B-1a lymphocytes attenuate insulin resistanceB cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartmentsCutting edge: Hierarchy of maturity of murine memory B cell subsets.Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells.A B-cell subset uniquely responsive to innate stimuli accumulates in aged miceUniversal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice.Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseB lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe diseaseAdaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance.Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune DiseaseRational clinical trial design for antibody mediated renal allograft injury.Chronic inflammation and aging: DNA damage tips the balance.Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells.Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).B-cell activating factor targeted therapy and lupus.Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.
P2860
Q26767363-65C573A5-3EEF-419A-9F56-DFAC83924991Q26771404-DCB84794-54AD-4CCD-814B-6989C3369DF9Q26852927-C87E87FA-2146-40AC-A7B8-54A61D0176C4Q27315065-C408DF11-3989-4229-A46D-5BEC501DFE1FQ30430255-FC9C1621-4019-4832-96B7-D0DD69C8ADF2Q33573335-C3754AA2-20B9-474F-B14E-82B564F765EAQ33688370-95C99C19-AF9A-4C1A-89B0-42533BBBA0DBQ33704093-DC32C74C-9B85-4BC4-B8C5-6A38107CDDBDQ33758475-979FA851-1DC1-4C85-B4C2-B470E4E55790Q33789638-102CE8AD-4BDF-4E67-8D67-BCE0A300C15DQ33803763-105BF410-1415-4118-86B0-9796CA3BF256Q33998360-A2E683A9-61C7-45F4-AC1C-F08BE07DCE51Q34013562-575D1957-61DF-4B02-9FBD-6954FEC20671Q34044394-996FE50A-B2D4-4302-B40B-306B4ABAF3E6Q34159016-56F3E0E0-3D58-4D34-9DA2-AE196613C031Q34268133-F5F2DF5E-3144-4774-9D17-48253D0C4EBEQ34688139-AA092BF1-24DB-4EA8-9308-72255E2535D5Q35004327-E45964AE-8CE9-4D3B-9DDB-67F4F6C7698CQ35007635-087BF238-0B2E-452F-906E-1BEDE8D66511Q35058903-3A19DABC-FF81-4FDF-BC3D-3C877A9AF41AQ35097452-3F904F36-BBCD-4AE2-86CA-F58B9BEB50AEQ35115832-88E18D7B-BC3F-4A61-B95D-0E0FF3F073B9Q35153782-F75DC73B-6CC6-4C11-8D1A-A87315C8827DQ35282148-476F16C0-6383-4AD8-BF8E-800FC56A940BQ35452032-CE5821F6-CD38-416E-927A-54D3CFB94F1DQ35602526-3A36E206-5F99-42A3-BE52-6B4A269AFB70Q35732635-60854E85-5E05-4B07-B9D5-F772C7573F0CQ35753282-EFCCD98C-46B7-49C3-BC7D-4CF32654EAECQ35798968-239C9215-9066-418E-B403-FC923DB422A4Q36097332-51254AE1-9D75-4CB5-BDA5-570319803DDDQ36173541-2C51CFCD-96CB-406B-BCC8-94CC38FBEEACQ36176981-06D840D3-4447-4BA8-9BA9-4698F51A3752Q36260505-1169B52B-1DA8-42BB-80AE-E7C0C878A367Q36271212-25F16240-5BB7-4210-BA7D-B94C9CA82DF3Q36504641-C189FF28-11FC-49DE-84D0-91A8C60E37BBQ36745567-F2716150-4628-4A48-B33E-476846E1EDD7Q36874604-120645EE-78F6-4BDC-A2CC-5F7F2F3B2132Q37038895-3ACE16A9-9965-418D-93A6-B0F4F5409771Q37170754-B6F699A9-BA37-47B7-9170-973E1828D193Q37293824-90231A64-32AD-4E63-AF27-C1E8C45BE7E9
P2860
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
BLyS inhibition eliminates pri ...... uired humoral immunity intact.
@en
type
label
BLyS inhibition eliminates pri ...... uired humoral immunity intact.
@en
prefLabel
BLyS inhibition eliminates pri ...... uired humoral immunity intact.
@en
P2093
P2860
P356
P1476
BLyS inhibition eliminates pri ...... uired humoral immunity intact.
@en
P2093
Chris Ward
Jean L Scholz
Jenni E Crowley
Juli P Miller
Mark J Shlomchik
Mary M Tomayko
Michael P Cancro
Natalie Steinel
Patrick J O'Neill
Radhika Goenka
P2860
P304
15517-15522
P356
10.1073/PNAS.0807841105
P407
P577
2008-10-01T00:00:00Z